Cerliponase alfa

Brineura 150 mg oplossing voor infusie

Oplossing voor infusieNetherlandsAuthorisedAuthorised 30 May 2017

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

BrineuraEuropean UnionAuthorised

BrineuraCanada · 150 MG / 5 ML · Solution · Biomarin International LimitedSame brand
Brineura 150 MG Solucion Para PerfusionSpain · 150 mg/ml · solución para perfusión · Biomarin International LimitedSame brand
BrineuraEuropean Union · BioMarin International LimitedSame brand
BrineuraCroatiaSame brand
BrineuraItaly · Soluzione per infusione · Biomarin International LimitedSame brand
BRINEURA 150 mgRomania · 150mg · sol. perf. · Biomarin International Limited

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Cerliponase alfa

Brineura 150 mg oplossing voor infusie

Oplossing voor infusieNetherlandsAuthorisedAuthorised 30 May 2017

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

BrineuraEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

BrineuraUnited States · 30MG/ML · injectable · Biomarin Pharm

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Cerliponase alfa
Dosage form: Oplossing voor infusie
Route: Intracerebraal gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 30 May 2017
Registration: EU/1/17/1192
Marketing authorisation holder: BioMarin International Limited
ATC code: A16AB17
Group: Alimentary tract and metabolism
Procedure: EU centralised
Supply: Uitsluitend recept
EMA product number: EMEA/H/C/004065
EU number: EU/1/17/1192